Synthesis and evaluation of novel potent HCV NS5A inhibitors.

Bioorg Med Chem Lett

Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Decatur, GA 30033, USA.

Published: July 2012

Judicious modifications to the structure of the previously reported HCV NS5A inhibitor 1, resulted in more potent anti-HCV compounds with similar and in some cases improved toxicity profiles. The synthesis of 19 new NS5A inhibitors is reported along with their ability to block HCV replication in an HCV 1b replicon system. For the most potent compounds chemical stability, stability in liver microsomes and inhibition of relevant CYP450 enzymes is also presented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389222PMC
http://dx.doi.org/10.1016/j.bmcl.2012.05.039DOI Listing

Publication Analysis

Top Keywords

hcv ns5a
8
ns5a inhibitors
8
synthesis evaluation
4
evaluation novel
4
novel potent
4
hcv
4
potent hcv
4
inhibitors judicious
4
judicious modifications
4
modifications structure
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!